The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients

American Journal of Surgery

Volumn 186, Issue 4, 2003, Pages 333-336

  Cox, Charles ^a   DuPont, Elisabeth L ^a   Furman, Ben ^a   Stowell, Nicholas ^a   Clark, John ^a   Ebert, Mark ^a   Diaz, Nils M ^a   Cantor, Alan ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Lymphatic mapping; Nonsentinel lymph nodes; Outcome; Prognosis; Recurrence; Sentinel lymph nodes

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; EVALUATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; STATISTICAL ANALYSIS; BREAST TUMOR; DISEASE FREE SURVIVAL; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 0142151075     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00266-6     Document Type: Article

References (8)

1. Canavese G., Gipponi M., Catturich A., et al. Sentinel lymph node mapping in early-stage breast cancer technical issues and results with vital blue dye mapping and radioguided surgery. J Surg Oncol. 74:2000;61-68.
2. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph node biopsy and axillary dissection in breast cancer results in a large series. J Natl Cancer Inst. 91:1999;368-373.
3. Shivers S., Cox C., Leight G., et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol. 9:2002;248-255.
4. Hansen N.M., Grube B.J., Giuliano A.E. The time has come to change the algorithm for the surgical management of early breast cancer. Arch Surg. 137:2002;1131-1135.
5. Abdessalam S.F., Zervos E.E., Prasad M., et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg. 182:2001;316-320.
6. Weaver D.L., Krag D.N., Ashikaga T., et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma a multicenter study. Cancer. 88:2000;1099-1107.
7. Cochran A.J., Morton D.L., Stern S., et al. Sentinel lymph nodes show profound downregualtion of antigen-presenting cells of the paracortex implications for tumorbiology and treatment. Mod Pathol. 14:2001;604-608.
8. Van der Wal B.C., Butzelaar R.M., van der Meij S., et al. Axillary lymph node ratio and total number of removed lymph nodes predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 28:2002;481-489.